OncoCyte Receives $2 Million in Proceeds from Early Exercise of Warrants
21 févr. 2017 06h30 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced the receipt...
OncoCyte Corporation to Present at the 19th Annual BIO CEO & Investor Conference and the 2017 Disruptive Growth & Healthcare Conference
13 févr. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...
OncoCyte Wins Buzz of BIO for the 2017 BIO CEO & Investor Conference
27 janv. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Jan. 27, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced that the...
OncoCyte to Present Interim Data from Its Lung Cancer Diagnostic Test Study at the American Thoracic Society Conference May 22, 2017
24 janv. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Jan. 24, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced that its abstract...
OncoCyte Provides Updated Timelines on Diagnostic Test Development and Commercialization Plans
04 janv. 2017 07h00 HE
|
OncoCyte Corporation
Breast Cancer Test Development Three to Six Months Ahead of Schedule; Commercial Launch Possible in Mid to Late 2018 Lung Cancer Test Development Two to Three Months Behind Schedule; Commercial...
OncoCyte Announces Publication of Breast Cancer Diagnostic Test Abstract; Poster to be Presented at the San Antonio Breast Cancer Symposium on December 9, 2016
14 nov. 2016 16h01 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, provided a summary of the...
OncoCyte Reports Third Quarter 2016 Financial Results
10 nov. 2016 16h01 HE
|
OncoCyte Corporation
Currently Processing Samples and Analyzing Results in its Lung Cancer Test Study; Continues to Project a Completion Date in Late December Conference Call to Discuss the Results...
OncoCyte Promotes Lyndal Hesterberg to Senior Vice President, Research and Development
08 nov. 2016 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests for the early detection of cancer, today announced...
UPDATE -- OncoCyte to Report Third Quarter Financial Results on November 10, 2016
02 nov. 2016 16h33 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...
OncoCyte to Report Third Quarter Financial Results on November 10, 2016
02 nov. 2016 15h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that it...